Sumitomo Dainippon Pharma Co. Ltd Financials

Market Capitalization ¥355.57 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	14.97
Forward PE	52.25
Price to Sales TTM	¥0.89
Price to Book MRQ	¥2.10
Enterprise to Revenue	1.68
Enterprise to EBITDA	17.31

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2024-06-30
Profit Margin	5.93%
Operating Margin	-0.19%
Return on Assets TTM	0.99%
Return on Equity TTM	14.52%

Income Statement

Revenue TTM	¥398,832,009,216
Revenue per Share TTM	¥1003.88
Quarterly Revenue Growth	32.80%
Gross Profit TTM	¥245,394,997,248
EBITDA	¥56,673,000,000
Net Income to Common TTM	¥23,633,999,872
Diluted EPS TTM	¥59.79
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	¥23,115,999,232
Total Cash per Share MRQ	¥58.18
Total Debt MRQ	¥
Total Debt to Equity MRQ	180.21
Current Ratio MRQ	1.05
Book Value per Share MRQ	¥426.59

Cash Flow

Operating Cash Flow TTM	¥16,499,999,744
Levered Free Cash Flow TTM	¥-12,362,125,312

4506 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	397,289,912
Float Shares	180,163,029
Avg 10 Volume	5,721,540
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	57.45%
% Held by Institutions	17.59%

Stock Price Summary

Beta	0.54
Fifty Two Week Low	¥388.00
Fifty Two Week High	¥1083.00
Fifty Two Week Change	55.75%
Day 50 MA	¥881.78
Day 200 MA	¥693.56

Dividends and Splits

Forward Annual Dividend Rate	¥14.00
Forward Annual Dividend Yield	1.56%
Trailing Annual Dividend Rate	¥21.00
Trailing Annual Dividend Yield	2.35%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2023-03-30
Last Split Factor
Last Split Date